# Emergency Medicine Medical Scenarios

## Scenario 1: Acute Chest Pain - STEMI

### Patient Profile
- **Name:** Thomas Wilson
- **Age:** 58 years
- **Gender:** Male
- **Weight:** 190 lbs (86 kg)
- **Height:** 5'9" (175 cm)
- **BMI:** 27.8
- **Occupation:** Construction foreman

### Medical History
- **Medical History:** 
  - Hypertension (10 years)
  - Type 2 diabetes (5 years)
  - Hyperlipidemia (8 years)
- **Family History:** Father died of MI at age 62
- **Social History:** Current smoker (20 cigarettes/day), occasional alcohol
- **Medications:** Lisinopril 20mg daily, Metformin 1000mg BID, Atorvastatin 20mg daily

### Chief Complaint
"I'm having terrible chest pain. It feels like someone is sitting on my chest and it's spreading to my left arm and jaw."

### Arrival Assessment
- **Arrival Time:** 14:30
- **Pain Onset:** 14:00 (30 minutes ago)
- **Pain Characteristics:**
  - Severe crushing/pressure pain
  - Radiating to left arm and jaw
  - Associated with diaphoresis and nausea
  - Pain Scale: 9/10

### Vital Signs
- **BP:** 165/98 mmHg
- **HR:** 105 bpm (regular)
- **RR:** 22 breaths/min
- **Temp:** 98.4°F (36.9°C)
- **SpO2:** 94% on room air

### Physical Examination
- **General:** Appears in severe distress, diaphoretic, anxious
- **Cardiovascular:** Tachycardic, regular rhythm, no murmurs
- **Respiratory:** Clear to auscultation bilaterally
- **Extremities:** Cool, clammy skin

### Emergency Department Protocol

#### Immediate Actions (First 10 minutes)
1. **MONA Protocol:**
   - **M**orphine: 2-4mg IV for pain control
   - **O**xygen: 2-4L via nasal cannula (SpO2 <94%)
   - **N**itroglycerin: 0.4mg sublingual (if BP allows)
   - **A**spirin: 162-325mg PO (chewed)

2. **IV Access:** Two large-bore IVs
3. **Cardiac Monitoring:** Continuous ECG monitoring
4. **Initial Labs:** Troponin, CBC, CMP, coags

#### ECG Findings
- **ST Elevation:** 2-3mm in leads II, III, aVF (inferior STEMI)
- **Reciprocal Changes:** ST depression in leads I, aVL

### Clinical Decision Points

#### STEMI Diagnosis Criteria
- **Chest pain** suggestive of cardiac ischemia
- **ST elevation** ≥1mm in two contiguous leads
- **Time from symptom onset** <12 hours

#### Reperfusion Strategy
1. **Primary PCI (Preferred):**
   - **Door-to-balloon time** target <90 minutes
   - **Cardiac catheterization lab** activation
   - **Transfer** if not available locally

2. **Fibrinolytic Therapy:**
   - If PCI unavailable within 120 minutes
   - **Door-to-needle time** <30 minutes

### Treatment Plan

#### Immediate Medications
1. **Antiplatelet Therapy:**
   - Aspirin 325mg PO (already given)
   - Clopidogrel 600mg loading dose
   - Consider ticagrelor or prasugrel

2. **Anticoagulation:**
   - Heparin bolus + infusion
   - OR Enoxaparin 1mg/kg SC

3. **Beta-blocker:**
   - Metoprolol 25mg PO (if no contraindications)
   - Hold if heart failure, bradycardia, or hypotension

#### Catheterization Lab Activation
- **STEMI Alert** called at 14:40
- **Cath lab team** activation
- **Door-to-balloon time** goal: <90 minutes

#### Post-PCI Management
1. **Dual Antiplatelet Therapy:**
   - Continue aspirin 81mg daily
   - P2Y12 inhibitor (clopidogrel/ticagrelor) for 12 months

2. **Secondary Prevention:**
   - High-intensity statin (atorvastatin 80mg)
   - ACE inhibitor/ARB
   - Beta-blocker continuation

### Complications to Monitor
1. **Arrhythmias:**
   - Ventricular tachycardia/fibrillation
   - Atrioventricular blocks (inferior MI)

2. **Mechanical Complications:**
   - Ventricular septal defect
   - Papillary muscle rupture
   - Free wall rupture

3. **Heart Failure:**
   - Cardiogenic shock
   - Pulmonary edema

### Outcome Metrics
- **Door-to-balloon time:** 65 minutes
- **TIMI flow grade:** 3 (complete reperfusion)
- **Peak troponin:** 45 ng/mL
- **Hospital course:** Uncomplicated
- **Discharge:** Day 4, cardiac rehabilitation enrolled

### Learning Objectives
- Rapid STEMI recognition and diagnosis
- Apply evidence-based reperfusion strategies
- Manage time-sensitive cardiac emergencies
- Coordinate multidisciplinary care
- Prevent and recognize complications

---

## Scenario 2: Acute Stroke - tPA Candidate

### Patient Profile
- **Name:** Margaret Chen
- **Age:** 75 years
- **Gender:** Female
- **Weight:** 140 lbs (64 kg)
- **Height:** 5'3" (160 cm)
- **BMI:** 24.4
- **Occupation:** Retired teacher

### Medical History
- **Medical History:**
  - Atrial fibrillation (3 years)
  - Hypertension (20 years)
  - Osteoarthritis
- **Medications:** Warfarin 3mg daily, Amlodipine 10mg daily, Acetaminophen PRN
- **Social History:** Non-smoker, lives alone
- **Family History:** Mother had stroke at age 70

### Chief Complaint
"Found by neighbor, unable to speak clearly and can't move her right side."

### Arrival Assessment
- **Arrival Time:** 16:45
- **Last Known Normal:** 15:30 (EMS report)
- **Witness:** Neighbor found patient at 16:15

### Initial Assessment (EMS)
- **FAST Exam:**
  - **F**ace: Right facial droop
  - **A**rm: Right arm weakness (can't hold up)
  - **S**peech: Slurred speech
  - **T**ime: 16:45 (call made immediately)

### Vital Signs
- **BP:** 170/95 mmHg
- **HR:** 110 bpm (irregular)
- **RR:** 16 breaths/min
- **Temp:** 98.6°F (37°C)
- **Blood Glucose:** 145 mg/dL

### NIHSS Score Assessment
- **Level of Consciousness:** 0 (alert)
- **Gaze:** 1 (partial gaze palsy)
- **Visual Fields:** 0 (no visual field loss)
- **Facial Palsy:** 2 (right complete facial palsy)
- **Motor Arm (Right):** 2 (drifts down)
- **Motor Arm (Left):** 0 (normal)
- **Motor Leg (Right):** 1 (drifts down)
- **Motor Leg (Left):** 0 (normal)
- **Limb Ataxia:** 0 (no ataxia)
- **Sensory:** 1 (mild sensory loss right side)
- **Language:** 1 (mild aphasia)
- **Dysarthria:** 2 (severe dysarthria)
- **Extinction/Inattention:** 0 (no neglect)
- **Total NIHSS:** 11

### Emergency Department Protocol

#### Immediate Actions (0-30 minutes)
1. **Neurological Assessment:**
   - Complete NIHSS
   - Glasgow Coma Scale
   - Pupillary response

2. **Critical Labs:**
   - CBC, CMP, coagulation studies
   - Troponin (rule out cardiac cause)
   - Blood glucose (correct hypoglycemia)

3. **Imaging:**
   - **Non-contrast CT head** (emergent)
   - **CTA head/neck** (if within time window)

#### CT Head Findings
- **No acute hemorrhage**
- **Early ischemic changes** in left MCA territory
- **No mass effect** or midline shift
- **Sulcal effacement** minimal

### Clinical Decision Points

#### IV tPA Eligibility Criteria
1. **Time Criteria:**
   - Last known normal: 15:30
   - Current time: 16:45
   - Time from onset: 75 minutes ✓ (<4.5 hours)

2. **Age:** 75 years ✓ (>18 years)

3. **Blood Pressure:**
   - Current: 170/95 mmHg
   - Target: <185/110 mmHg ✓
   - Can be treated with medications

4. **Blood Glucose:**
   - Current: 145 mg/dL ✓ (>50 mg/dL)

5. **Warfarin Therapy:**
   - INR: 2.8 (therapeutic range)
   - **CAUTION:** INR >1.7 typically contraindicated
   - Requires careful risk-benefit analysis

#### tPA Contraindications Review
- **Hemorrhagic stroke:** None identified ✓
- **Recent surgery/trauma:** None ✓
- **Bleeding disorder:** Therapeutic warfarin (relative CI)
- **Intracranial neoplasm:** None identified ✓

### Treatment Decision

#### tPA Administration Decision
- **Risk-Benefit Analysis:**
  - **Benefits:** Potential significant improvement
  - **Risks:** Bleeding complications (higher risk with warfarin)
  - **Family discussion:** Benefits outweigh risks

- **Alternative:** Endovascular therapy consideration
  - **Time window:** Up to 24 hours with perfusion imaging
  - **Eligibility:** Large vessel occlusion
  - **CTA results:** Left MCA occlusion confirmed

### Treatment Plan

#### IV Thrombolysis
1. **Alteplase Dose:**
   - 0.9 mg/kg = 58mg (maximum 90mg)
   - 10% as IV bolus (5.8mg over 1 minute)
   - 90% as infusion (52.2mg over 60 minutes)

2. **Monitoring Protocol:**
   - **NIHSS:** Every 15 minutes for 2 hours
   - **Blood pressure:** Every 15 minutes
   - **Neurological checks:** Continuous

#### Endovascular Therapy
- **CTA confirmed:** Left MCA occlusion
- **Door-to-groin time:** <90 minutes target
- **Mechanical thrombectomy:** Standard of care

### Post-tPA Management

#### Immediate (0-24 hours)
1. **Complications Monitoring:**
   - **Hemorrhagic transformation:** Repeat CT at 24 hours
   - **Angioedema:** Monitor for airway compromise
   - **Blood pressure:** Maintain <180/105 mmHg

2. **Anticoagulation:**
   - **Continue warfarin** (therapeutic INR)
   - **Resume** if held for procedure

#### Secondary Prevention
1. **Antiplatelet Therapy:**
   - **Aspirin 325mg** (24 hours post-tPA if no bleeding)
   - **Dual antiplatelet** consideration

2. **Risk Factor Management:**
   - **Blood pressure:** Target <130/80 mmHg
   - **Cholesterol:** High-intensity statin
   - **Atrial fibrillation:** Continue anticoagulation

### Outcome
- **tPA administration:** 17:00 (90 minutes from onset)
- **Door-to-groin:** 17:30 (catheterization)
- **Post-procedure:** Complete reperfusion (TICI 3)
- **24-hour NIHSS:** 3 (significant improvement)
- **Discharge disposition:** Inpatient rehabilitation

### Learning Objectives
- Apply rapid stroke assessment protocols
- Calculate NIHSS score accurately
- Understand tPA eligibility criteria
- Manage anticoagulation during stroke
- Coordinate endovascular therapy

---

## Scenario 3: Septic Shock

### Patient Profile
- **Name:** Carlos Rodriguez
- **Age:** 67 years
- **Gender:** Male
- **Weight:** 165 lbs (75 kg)
- **Height:** 5'7" (170 cm)
- **BMI:** 25.5
- **Occupation:** Retired factory worker

### Medical History
- **Medical History:**
  - Type 2 diabetes (15 years)
  - Chronic kidney disease (stage 3)
  - Hypertension (20 years)
- **Medications:** Metformin 1000mg BID, Lisinopril 20mg daily, Insulin glargine 20 units daily
- **Social History:** Lives with wife, independent

### Chief Complaint
"My husband has been confused and very weak today. He has a fever and his breathing seems rapid."

### Presentation Timeline
- **2 days ago:** Mild fever, decreased appetite
- **1 day ago:** Increased confusion, decreased urination
- **Today:** Severe weakness, shortness of breath
- **Arrival:** Via EMS

### Arrival Assessment
- **Vital Signs:**
  - **BP:** 85/45 mmHg
  - **HR:** 130 bpm
  - **RR:** 32 breaths/min
  - **Temp:** 104.2°F (40.1°C)
  - **SpO2:** 88% on room air
  - **GCS:** 13 (E4V4M5)

### Physical Examination
- **General:** Appears severely ill, lethargic
- **Skin:** Warm, flushed, mottled
- **Cardiovascular:** Tachycardic, no murmurs
- **Respiratory:** Tachypneic, crackles bilateral lower lobes
- **Abdomen:** Diffuse tenderness, no rebound
- **Extremities:** Cool, delayed capillary refill

### Septic Shock Criteria (Sepsis-3)
1. **Infection suspected/confirmed** ✓
2. **qSOFA ≥2:**
   - **Respiratory rate ≥22** ✓ (32/min)
   - **Altered mentation** ✓ (GCS 13)
   - **Systolic BP ≤100** ✓ (85 mmHg)
3. **Lactate ≥4 mmol/L** (pending results)

### Sepsis Protocol

#### Immediate Actions (First Hour)
1. **Blood Cultures:** Two sets before antibiotics
2. **Lactate:** Initial and repeat
3. **Broad-spectrum Antibiotics:**
   - Piperacillin-tazobactam 4.5g IV
   - Vancomycin 15-20mg/kg IV

3. **Fluid Resuscitation:**
   - 30 mL/kg crystalloid bolus (2.25L)
   - Assess fluid responsiveness

4. **Source Control:**
   - Urinalysis and culture
   - Chest X-ray
   - Consider CT if stable

### Laboratory Results
- **CBC:** WBC 18,000, Hgb 11.2, Platelets 95,000
- **CMP:** Creatinine 2.8 (baseline 1.4), BUN 65
- **Lactate:** 6.2 mmol/L
- **Procalcitonin:** 8.5 ng/mL
- **Blood Cultures:** Pending (2 sets drawn)
- **Urinalysis:** >100 WBC/hpf, bacteria present

### Diagnostic Assessment
- **Primary Source:** Pneumonia (bilateral infiltrates on CXR)
- **Secondary Issue:** Urosepsis (positive urinalysis)
- **Renal Function:** Acute kidney injury on chronic

### Clinical Decision Points

#### Septic Shock Management
1. **Hemodynamic Support:**
   - **Target MAP ≥65 mmHg**
   - **Fluid resuscitation** first-line
   - **Vasopressors** if MAP remains <65

2. **Antibiotic Selection:**
   - **Broad-spectrum coverage** for suspected sources
   - **Pseudomonas coverage** (piperacillin-tazobactam)
   - **MRSA coverage** (vancomycin)

3. **Monitoring Parameters:**
   - **Central venous pressure** (8-12 mmHg target)
   - **Mixed venous O2 saturation** (>65%)
   - **Lactate clearance** (goal >10% in 2 hours)

### Treatment Plan

#### Hour 1 Bundle Completion
1. **Antibiotics administered** (within 1 hour)
2. **Fluid resuscitation** (2.25L crystalloid)
3. **Blood cultures** (2 sets)
4. **Lactate measurement** (6.2 mmol/L)

#### Ongoing Resuscitation
1. **Fluid Management:**
   - Additional crystalloid as needed
   - Consider albumin if persistent shock
   - Monitor for fluid overload

2. **Vasopressor Therapy:**
   - **Norepinephrine** first-line (start at 0.1 mcg/kg/min)
   - **Target MAP ≥65 mmHg**
   - Consider vasopressin as adjunct

3. **Mechanical Ventilation:**
   - **Respiratory failure** (hypoxemic, hypercapnic)
   - **Altered mental status**
   - **Work of breathing** too high

### Source Control
1. **Pneumonia Management:**
   - **Antibiotic coverage** appropriate
   - **Oxygen support** escalation
   - **Consider ICU** admission

2. **Urosepsis Component:**
   - **Continue antibiotics** (penetrates urinary tract)
   - **Monitor renal function**
   - **Consider urological consultation**

### ICU Management

#### Day 1-2
1. **Hemodynamic Monitoring:**
   - **Arterial line placement**
   - **Central venous catheter**
   - **Swan-Ganz catheter** if needed

2. **Organ Support:**
   - **Mechanical ventilation** settings
   - **Renal replacement therapy** consideration
   - **Stress ulcer prophylaxis**

#### Day 3-7
1. **Antibiotic De-escalation:**
   - **Culture results** (3-5 days)
   - **Narrow spectrum** based on sensitivities
   - **Duration** 7-10 days for pneumonia

2. **Recovery Planning:**
   - **Weaning trials** when improved
   - **Renal function** recovery assessment
   - **Mobilization** when stable

### Outcome
- **ICU length of stay:** 5 days
- **Hospital length of stay:** 12 days
- **Renal function:** Returned to baseline
- **Discharge disposition:** Home with wife

### Learning Objectives
- Recognize septic shock early
- Apply Surviving Sepsis Campaign bundles
- Manage hemodynamic support
- Perform appropriate source control
- Coordinate multidisciplinary care

---

## Additional Emergency Scenarios

### Diabetic Ketoacidosis (DKA)
- **Patient:** 28-year-old with type 1 diabetes, altered mental status
- **Key points:** Anion gap metabolic acidosis, insulin therapy, electrolyte management
- **Learning objectives:** Endocrine emergencies

### Anaphylaxis
- **Patient:** 35-year-old with bee sting, respiratory distress
- **Key points:** Epinephrine administration, airway management
- **Learning objectives:** Allergic emergencies

### Acute Asthma Exacerbation
- **Patient:** 45-year-old with severe asthma attack
- **Key points:** Respiratory distress, bronchodilator therapy
- **Learning objectives:** Respiratory emergencies

### Gastrointestinal Bleeding
- **Patient:** 65-year-old with hematemesis and melena
- **Key points:** Hemodynamic instability, endoscopy timing
- **Learning objectives:** Bleeding emergencies

---

## References and Guidelines

### Primary Guidelines
1. **American Heart Association Guidelines for STEMI Management**
2. **American Stroke Association Stroke Guidelines**
3. **Surviving Sepsis Campaign Guidelines (2021)**
4. **Advanced Cardiac Life Support (ACLS) Guidelines**

### Key Evidence Sources
- NINDS tPA trials
- REACT trials (endovascular therapy)
- EGDT studies (early goal-directed therapy)
- Vasopressor studies in septic shock

### Quality Metrics
- Door-to-needle time for stroke
- Time to antibiotics in sepsis
- Door-to-balloon time for STEMI
- Bundle compliance rates

---

*Note: All scenarios are fictional and created for educational purposes. Patient information has been de-identified and modified for demonstration.*